The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125315992 12531599 2 F 20151025 20160621 20160706 20160707 EXP CN-009507513-1511CHN012445 MERCK 39.00 YR M Y 68.00000 KG 20160707 MD CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125315992 12531599 1 PS EMEND APREPITANT 1 Oral 125 MG, ONCE 160 MG K010950 21549 125 MG CAPSULE 1X
125315992 12531599 2 SS EMEND APREPITANT 1 Oral 80 MG, QD 160 MG 21549 80 MG CAPSULE QD
125315992 12531599 3 C GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Intravenous drip 1.8 G D1,5 + CISPLATIN INJECTION 45MG D2 TO D4(TREATMENT CYCLE 1) 0 1.8 G INJECTION
125315992 12531599 4 C CISPLATIN. CISPLATIN 1 Intravenous drip GEMCITABINE INJECTION 1.8G D1, 5 + CISPLATIN INJECTIO 5 MG, DAY 2 TO DAY 4 TREATMENT CYCLE 1/UNKNOWN 0 45 MG INJECTION
125315992 12531599 5 C LANSOPRAZOLE. LANSOPRAZOLE 1 Intravenous drip 30 MG, DAILY 180 MG U 0 30 MG INJECTION QD
125315992 12531599 6 C AMIFOSTINE. AMIFOSTINE 1 Intravenous drip 400 MG, DAILY 2400 MG U 0 400 MG INJECTION QD
125315992 12531599 7 C PALONOSETRON HYDROCHLORIDE. PALONOSETRON HYDROCHLORIDE 1 Intravenous (not otherwise specified) TOTAL DAILY DOSE: 0.25 MG (QD) U 0 INJECTION QD
125315992 12531599 8 C PALONOSETRON HYDROCHLORIDE. PALONOSETRON HYDROCHLORIDE 1 Intravenous drip 0.25 MG, DAILY U 0 INJECTION QD
125315992 12531599 9 C MONOSIALOGANGLIOSIDE SODIUM 2 Intravenous drip 80 MG, DAILY 480 MG U 0 80 MG INJECTION QD
125315992 12531599 10 C ZHEN QI FU ZHENG 2 Intravenous drip 250 ML/CC, DAILY 1500 ML U 0 250 ML INJECTION QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125315992 12531599 1 Prophylaxis of nausea and vomiting
125315992 12531599 3 Chemotherapy
125315992 12531599 4 Chemotherapy
125315992 12531599 5 Prophylaxis against gastrointestinal ulcer
125315992 12531599 6 Prophylaxis
125315992 12531599 7 Prophylaxis of nausea and vomiting
125315992 12531599 8 Allergy prophylaxis
125315992 12531599 9 Nervous system disorder
125315992 12531599 10 Supplementation therapy

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125315992 12531599 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125315992 12531599 1 20151021 20151021 0
125315992 12531599 2 20151022 20151023 0
125315992 12531599 3 20151020 20151024 0
125315992 12531599 4 20151021 20151024 0
125315992 12531599 5 20151020 20151026 0
125315992 12531599 6 20151020 20151025 0
125315992 12531599 7 20151020 20151020 0
125315992 12531599 8 20151021 20151028 0
125315992 12531599 9 20151020 20151026 0
125315992 12531599 10 20151020 20151026 0